[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100649336":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":24,"centralContacts":28,"locations":35,"responsibleParty":50,"collaborators":18,"id":52,"slug":53,"hasResults":54,"nctId":55,"briefTitle":56,"officialTitle":57,"acronym":58,"eligibilityCriteria":59,"healthyVolunteers":54,"sex":60,"minAge":61,"maxAge":18,"enrollmentInfo":62,"targetDuration":18,"studyType":65,"phases":66,"briefSummary":68,"conditions":69,"keywords":71,"overallStatus":77,"whyStopped":18,"lastUpdateSubmitDate":78,"lastUpdatePostDateStruct":79,"startDateStruct":82,"completionDateStruct":84,"leadSponsor":86,"locationsCount":87},{"fullName":5,"class":6},"National Cancer Centre, Singapore","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"CCC Intervention Arm","EXPERIMENTAL","Each participant will be assigned a CCC and receive 6 CCC sessions over the course of 3 months.",[13],"Other: CCC Intervention",{"label":15,"type":16,"description":17,"interventionNames":18},"Usual Care Arm","NO_INTERVENTION","Each participant will continue to be followed by the oncologist and receive usual care but will not receive CCC intervention.",null,[20],{"type":6,"name":21,"description":22,"armGroupLabels":23,"otherNames":18},"CCC Intervention","CCC sessions will be on exploring participant's illness journey thus far, their concerns, values and priorities.",[9],[25],{"name":26,"affiliation":5,"role":27},"Shirlyn NEO Hui Shan, MD, PhD","STUDY_CHAIR",[29,33],{"name":26,"role":30,"phone":31,"phoneExt":18,"email":32},"CONTACT","63065838","shirlyn.neo.h.s@singhealth.com.sg",{"name":34,"role":30,"phone":18,"phoneExt":18,"email":18},"Benton PT TAM, MSc",[36],{"facility":37,"status":18,"city":38,"state":18,"zip":39,"country":38,"countryCode":40,"cosmosGeoPoint":41,"geoPoint":46,"contacts":47},"National Cancer Center, Singapore","Singapore","168583","SG",{"type":42,"coordinates":43},"Point",[44,45],103.85007,1.28967,{"lat":45,"lon":44},[48,49],{"name":26,"role":30,"phone":18,"phoneExt":18,"email":18},{"name":18,"role":30,"phone":31,"phoneExt":18,"email":32},{"type":51,"investigatorFullName":18,"investigatorTitle":18,"investigatorAffiliation":18,"oldNameTitle":18,"oldOrganization":18},"SPONSOR","100649336","effectiveness-acceptability-and-feasibility-of-a-communication-and-care-coordinator-ccc-model-in-facilitating-serious-illness-communication-sic-and-care-in-patients-with-cancer-100649336",false,"NCT07733973","Effectiveness, Acceptability and Feasibility of a Communication and Care Coordinator (CCC) Model in Facilitating Serious Illness Communication (SIC) and Care in Patients With Cancer","Evaluating the Effectiveness, Acceptability and Feasibility of a Communication and Care Coordinator (CCC) Model in Facilitating Serious Illness Communication (SIC) and Care in Patients With Cancer","CCC-Cancer","Inclusion Criteria:\n\nPatient Participants\n\n* Aged 21 and above\n* Diagnosed with (a) advanced cancer (stage 3 or 4) or (b) non-advanced cancer, but at high risk of recurrence\n* Able to speak English or Chinese, irrespective of race\n\nClinicians\n\n* Oncologists who are at least of designation of associate consultant and above in NCCS\n\nExclusion Criteria:\n\nPatient Participants\n\n* Confused\u002Fnot able to sign informed consent\n* Diagnosed with untreated hearing or visual loss or psychiatric illness\n\nClinicians\n\n* Overseas\u002Fnot practising in Singapore for a significant amount of time","ALL","21 Years",{"count":63,"type":64},560,"ESTIMATED","INTERVENTIONAL",[67],"NA","The goal of this clinical trial is to evaluate the communication and care coordinator (CCC) model in a national cancer institute and assess the utility of the model in facilitating serious illness communication (SIC) and care for patients with cancer.\n\nThe study aims are:\n\n* To assess the effectiveness of the CCC model in improving patient outcomes.\n* To assess the effectiveness of the CCC model in increasing rates of SIC and advance care planning (ACP) record documentation.\n* To assess the acceptability of the CCC model to patients and clinicians.\n* To evaluate the feasibility of implementing a CCC model in oncology care.\n\nResearchers will compare results from the CCC intervention arm and usual care arm, to see if the CCC model can help improve patient outcomes and facilitate SIC between patients and clinicians.\n\nPatient participants will:\n\n* Follow the assignment of their clinician, who will be assigned randomly to either the usual care group or the intervention group.\n* Be assigned a CCC and receive 6 CCC sessions over the course of 3 months (if assigned to CCC intervention arm).\n* Complete 3 study assessment visits at baseline, Week 6, and 3 months\n* Be invited to a one-time interview to share their study experience (optional, if selected and if in CCC intervention arm).",[70],"Cancer",[72,73,74,75,76],"Communication and Care Coordinators","Serious Illness Communication","Healthcare Communication","Cancer Care","Oncology","NOT_YET_RECRUITING","2026-07-24",{"date":80,"type":81},"2026-07-29","ACTUAL",{"date":83,"type":64},"2026-08-01",{"date":85,"type":64},"2029-06-30",{"name":5,"class":6},1]